Daniel Enderle

2.4k total citations · 1 hit paper
18 papers, 1.6k citations indexed

About

Daniel Enderle is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniel Enderle has authored 18 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 10 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniel Enderle's work include Cancer Genomics and Diagnostics (8 papers), Extracellular vesicles in disease (7 papers) and Lung Cancer Treatments and Mutations (5 papers). Daniel Enderle is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Extracellular vesicles in disease (7 papers) and Lung Cancer Treatments and Mutations (5 papers). Daniel Enderle collaborates with scholars based in Germany, United States and United Kingdom. Daniel Enderle's co-authors include Mikkel Noerholm, Johan Skog, D.H. Roberts, Sudipto K. Chakrabortty, Yu Wang, Xandra O. Breakefield, James Hurley, Alexandra Spiel, Romy Mueller and Eric Lader and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Daniel Enderle

18 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosome-based liquid biopsies in cancer: opportunities and challenges

2021 631 citations Yu Wang, James Hurley et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Enderle Germany	12	1.4k	870	174	171	159	18	1.6k
Travis J. Antes United States	16	1.1k 0.8×	628 0.7×	125 0.7×	102 0.6×	36 0.2×	31	1.2k
Haidar Al Saffar Australia	6	1.2k 0.9×	647 0.7×	77 0.4×	101 0.6×	52 0.3×	9	1.3k
Wittaya Suwakulsiri Australia	9	1.2k 0.9×	715 0.8×	93 0.5×	258 1.5×	119 0.7×	12	1.4k
Bin‐Tao Pan United States	7	1.7k 1.2×	881 1.0×	90 0.5×	93 0.5×	133 0.8×	12	1.9k
Alanna Sedgwick United States	10	1.5k 1.1×	724 0.8×	59 0.3×	134 0.8×	148 0.9×	13	1.7k
Svetlana Tamkovich Russia	22	1.2k 0.9×	889 1.0×	144 0.8×	108 0.6×	216 1.4×	79	1.6k
Alin Rai Australia	22	2.7k 2.0×	1.5k 1.8×	151 0.9×	424 2.5×	253 1.6×	43	3.1k
Luize G. Lima Brazil	17	1.4k 1.0×	822 0.9×	118 0.7×	195 1.1×	220 1.4×	23	1.8k
Ira Winer United States	20	971 0.7×	197 0.2×	102 0.6×	174 1.0×	430 2.7×	85	1.8k
Mari Olsen United States	12	3.0k 2.2×	2.3k 2.6×	73 0.4×	37 0.2×	368 2.3×	19	3.3k

Countries citing papers authored by Daniel Enderle

Since Specialization

Citations

This map shows the geographic impact of Daniel Enderle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Enderle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Enderle more than expected).

Fields of papers citing papers by Daniel Enderle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Enderle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Enderle. The network helps show where Daniel Enderle may publish in the future.

Co-authorship network of co-authors of Daniel Enderle

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Enderle. A scholar is included among the top collaborators of Daniel Enderle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Enderle. Daniel Enderle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

García‐Silva, Susana, Daniel Enderle, Jean-Charles Sanchez, et al.. (2023). Improved Sensitivity in BRAFV600E Detection in Combined Tissue and Extracellular Vesicle-Based Liquid Biopsy in Melanoma. Journal of Investigative Dermatology. 143(8). 1606–1610. 3 indexed citations

Kretschmer, Alexander, Eric Margolis, Ronald Tutrone, et al.. (2022). Validation of a CE-IVD, urine exosomal RNA expression assay for risk assessment of prostate cancer prior to biopsy. Scientific Reports. 12(1). 4777–4777. 31 indexed citations

Wirtz, Ralph M., Richard Watts, Ronny Kellner, et al.. (2022). FGFR testing and urine-based risk straticfication from matched tissue and urine samples within the prospective real-world clinicopathological register trial: BRIDGister.. Journal of Clinical Oncology. 40(6_suppl). 469–469. 1 indexed citations

Enderle, Daniel & Mikkel Noerholm. (2022). Are extracellular vesicles ready for the clinical laboratory?. Journal of Laboratory Medicine. 46(4). 273–282. 13 indexed citations

Wang, Yu, James Hurley, D.H. Roberts, et al.. (2021). Exosome-based liquid biopsies in cancer: opportunities and challenges. Annals of Oncology. 32(4). 466–477. 631 indexed citations breakdown →

Repetto, Ombretta, Federica Lovisa, Daniel Enderle, et al.. (2021). Proteomic Exploration of Plasma Exosomes and Other Small Extracellular Vesicles in Pediatric Hodgkin Lymphoma: A Potential Source of Biomarkers for Relapse Occurrence. Diagnostics. 11(6). 917–917. 20 indexed citations

Wirtz, Ralph M., Richard Watts, Ronny Kellner, et al.. (2021). FGFR testing from matched tissue and urine samples within the prospective real world clinico-pathological register trial BRIDGister.. Journal of Clinical Oncology. 39(15_suppl). e16532–e16532. 1 indexed citations

Enderle, Daniel, et al.. (2020). Extracellular vesicles from plasma have higher tumour RNA fraction than platelets. Journal of Extracellular Vesicles. 9(1). 1741176–1741176. 34 indexed citations

Brinkmann, Kay, et al.. (2018). Exosome liquid biopsies of NSCLC patients for longitudinal monitoring of ALK fusions and resistance mutations.. Journal of Clinical Oncology. 36(15_suppl). e24090–e24090. 11 indexed citations

10.

Krug, Anne K., Daniel Enderle, Chris Karlovich, et al.. (2017). Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma. Annals of Oncology. 29(3). 700–706. 208 indexed citations

11.

Enderle, Daniel, Alexandra Spiel, Christine M. Coticchia, et al.. (2015). Characterization of RNA from Exosomes and Other Extracellular Vesicles Isolated by a Novel Spin Column-Based Method. PLoS ONE. 10(8). e0136133–e0136133. 305 indexed citations

12.

Sullivan, Ryan J., Vincent O’Neill, Kay Brinkmann, et al.. (2015). Plasma-based monitoring of BRAF mutations during therapy for malignant melanoma (MM) using combined exosomal RNA and cell-free DNA analysis.. Journal of Clinical Oncology. 33(15_suppl). 9017–9017. 8 indexed citations

13.

Krug, Anne K., Chris Karlovich, Tina Koestler, et al.. (2015). Abstract B136: Plasma EGFR mutation detection using a combined exosomal RNA and circulating tumor DNA approach in patients with acquired resistance to first-generation EGFR-TKIs. Molecular Cancer Therapeutics. 14(12_Supplement_2). B136–B136. 11 indexed citations

14.

Brinkmann, Kay, Daniel Enderle, Alexandra Spiel, et al.. (2015). Detection of EGFR activating and T790M resistance mutations in plasma of lung cancer patients using combined exosomal RNA and cfDNA capture.. Journal of Clinical Oncology. 33(15_suppl). e22156–e22156. 2 indexed citations

15.

Brinkmann, Kay, Daniel Enderle, Tina Koestler, et al.. (2015). Abstract 545: Plasma-based diagnostics for detection of EML4-ALK fusion transcripts in NSCLC patients. Cancer Research. 75(15_Supplement). 545–545. 11 indexed citations

16.

Enderle, Daniel, Kay Brinkmann, Tina Koestler, et al.. (2014). 454 Monitoring therapy response and resistance mutations in circulating RNA and DNA of plasma from patients with malignant melanoma. European Journal of Cancer. 50. 149–149. 2 indexed citations

17.

Enderle, Daniel, Christian Beisel, Michael Stadler, et al.. (2010). Polycomb preferentially targets stalled promoters of coding and noncoding transcripts. Genome Research. 21(2). 216–226. 129 indexed citations

18.

Till, Susanne, Erwan Lejeune, Rolf Thermann, et al.. (2007). A conserved motif in Argonaute-interacting proteins mediates functional interactions through the Argonaute PIWI domain. Nature Structural & Molecular Biology. 14(10). 897–903. 182 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact